Trial Profile
Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Pregnant Women at High Risk Following C.S.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2023
Price :
$35
*
At a glance
- Drugs Carbetocin (Primary) ; Misoprostol (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- 30 Jan 2021 Planned End Date changed from 1 Aug 2019 to 1 Aug 2021.
- 30 Jan 2021 Planned primary completion date changed from 1 Aug 2019 to 1 Aug 2021.
- 21 Nov 2018 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.